The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective

References

• Agency for Toxic Substances and Disease Registry. ATSDR's Final Criteria for Determining the Appropriateness of a Medical Monitoring Program Under CERCLA. Federal Register. 1995;60:388–404.
   Google Scholar
• Gochfeld M. Medical surveillance and screening in the workplace: complementary preventive strategies. Environ Res. 1992;59:67–80.
   PubMed Web of Science ®Google Scholar
• Guzelian CP, Hillner BE, Guzelian PS. Quantitative methodology for determining the need for exposure-prompted medical monitoring. Indiana Law J. 2004;79:57.
   Web of Science ®Google Scholar
• United States Preventive Services Task Force. Procedure Manual. In: Agency for Healthcare Research and Quality, editor; 2008.
   Google Scholar
• Beeler MF, Sappenfield R. Medical monitoring. What is it, how can it be improved? Am J Clin Pathol. 1987;87:285–288.
   PubMed Web of Science ®Google Scholar
• Halperin WE, Ratcliffe J, Frazier TM, et al. Medical screening in the workplace: proposed principles. J Occup Environ Med. 1986;28:547–552.
   Web of Science ®Google Scholar
• Breysse PN, Weaver V, Cadorette M, et al. Development of a medical examination program for former workers at a Department of Energy national laboratory. Am J Ind Med. 2002;42:443–454.
   PubMed Web of Science ®Google Scholar
• Daugherty NM, Falk RB, Furman FJ, et al. Former radiation worker Medical Surveillance Program at Rocky Flats. Health Phys. 2001;80:544–551.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Hall EJ. Cancer risks from CT scans: now we have data, What Next? Radiology. 2012;265:330–331.
   PubMed Web of Science ®Google Scholar
• Gochfeld M, Bogden JD, Louria DB. Ethics and principles in medical monitoring of populations exposed to environmental hazards. J Occup Environ Med. 2009;51:1363–1366.
   PubMed Web of Science ®Google Scholar
• Mandel JH, Maldonado G. Comprehensive medical monitoring after environmental contamination: not ready for prime time. J Occup Environ Med. 2010;52:465. Author reply -6.
   PubMed Web of Science ®Google Scholar
• Bourne R. Medical monitoring without physical injury: the least justice can do for those industry has terrorized with poisonous products. SMU Law Rev. 2005;58:251–302.
   PubMedGoogle Scholar
• Studdert DM, Mello MM, Brennan TA. Medical monitoring for pharmaceutical injuries: tort law for the public's health? JAMA. 2003;289:889–894.
   PubMed Web of Science ®Google Scholar
• LaRatta AR, Paszamant BS. Diagnosing medical monitoring costs under CERCLA: checking for a pulse. Villanova Environ Law J. 1996;7:81–107.
   Google Scholar
• Saxon AE. Tobacco litigation: medical monitoring of healthy smokers. J Law Med Ethics. 2002;30:755–758.
   PubMed Web of Science ®Google Scholar
• Schwartz VE, Lorber L, Laird EJ. Medical monitoring: the right way and the wrong way. Missouri Law Rev. 2005;70:349.
   Google Scholar
• McDavid GE, Laccabue MG. 2006: a difficult year for medical monitoring proponents. Reed Smith LP 2007 January 8; 2007.
   Google Scholar
• Williams ME. The scientific case against medical monitoring. In-House Defense Q. 2011;40–51.
   Google Scholar
• Gonzalez EA, Valori RW. Medical monitoring claims are viable in Florida. Florida Bar J. 2001;75:66.
   Google Scholar
• Jack W. Leach, et al. v E.I. du Pont de Nemours and Co Class Action Settlement Agreement.
   Google Scholar
• Roth BL. Drugs and valvular heart disease. N Engl J Med. 2007;356:6–9.
   PubMed Web of Science ®Google Scholar
• United States District Court for the Eastern District of Pennsylvania. In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Products Liability Litigation. MDL Docket No 1203; 28 August 2000.
   Google Scholar
• Wones R, Pinney SM, Buckholz JM, et al. Medical monitoring: a beneficial remedy for residents living near an environmental hazard site. J Occup Environ Med. 2009;51:1374–1383.
   PubMed Web of Science ®Google Scholar
• US Centers for Disease Control and Prevention. Fernald Risk Assessment Project 2010. Available from: http://www.cdc.gov/nceh/radiation/fernald/default.htm
   Google Scholar
• Moline JM, Herbert R, Levin S, et al. WTC medical monitoring and treatment program: comprehensive health care response in aftermath of disaster. Mt Sinai J Med. 2008;75:67–75.
   PubMedGoogle Scholar
• Berger KI, Reibman J, Oppenheimer BW, et al. Lessons from the World Trade Center disaster: airway disease presenting as restrictive dysfunction. Chest. 2013;144:249–257.
   PubMed Web of Science ®Google Scholar
• de la Hoz RE, Mallea JM, Kramer SJ, et al. Polysomnographic diagnoses among former world trade center rescue workers and volunteers. Arch Environ Occup Health. 2012;67:239–242.
   PubMed Web of Science ®Google Scholar
• Ekenga CC, Friedman-Jimenez G. Epidemiology of respiratory health outcomes among World Trade Center disaster workers: review of the literature 10 years after the September 11, 2001 terrorist attacks. Disaster Med Public Health Prep. 2011;5 Suppl 2:S189–S196.
   PubMed Web of Science ®Google Scholar
• Feldman DM, Baron SL, Bernard BP, et al. Symptoms, respirator use, and pulmonary function changes among New York City firefighters responding to the World Trade Center disaster. Chest. 2004;125:1256–1264.
   PubMed Web of Science ®Google Scholar
• Guidotti TL, Prezant D, de la Hoz RE, et al. The evolving spectrum of pulmonary disease in responders to the World Trade Center tragedy. Am J Ind Med. 2011;54:649–660.
   PubMed Web of Science ®Google Scholar
• Jordan HT, Brackbill RM, Cone JE, et al. Mortality among survivors of the Sept 11, 2001, World Trade Center disaster: results from the World Trade Center Health Registry cohort. Lancet. 2011;378:879–887.
   PubMed Web of Science ®Google Scholar
• Nolan A, Naveed B, Comfort AL, et al. Inflammatory biomarkers predict airflow obstruction after exposure to World Trade Center dust. Chest. 2012;142:412–418.
   PubMed Web of Science ®Google Scholar
• Schenck EJ, Echevarria GC, Girvin FG, et al. Enlarged pulmonary artery is predicted by vascular injury biomarkers and is associated with WTC-Lung Injury in exposed fire fighters: a case–control study. BMJ Open. 2014;4:e005575.
   PubMedGoogle Scholar
• Soo J, Webber MP, Hall CB, et al. Pulmonary function predicting confirmed recovery from lower-respiratory symptoms in World Trade Center-exposed firefighters, 2001 to 2010. Chest 2012;142:1244–1250.
   PubMed Web of Science ®Google Scholar
• Udasin I, Schechter C, Crowley L, et al. Respiratory symptoms were associated with lower spirometry results during the first examination of WTC responders. J Occup Environ Med. 2011;53:49–54.
   PubMed Web of Science ®Google Scholar
• Webber MP, Moir W, Crowson CS, et al. Post-September 11, 2001, incidence of systemic autoimmune diseases in world trade center-exposed firefighters and emergency medical service workers. Mayo Clin Proc. 2016;91:23–32.
   PubMed Web of Science ®Google Scholar
• Wisnivesky JP, Teitelbaum SL, Todd AC, et al. Persistence of multiple illnesses in World Trade Center rescue and recovery workers: a cohort study. Lancet. 2011;378:888–897.
   PubMed Web of Science ®Google Scholar
• Zvolensky MJ, Kotov R, Schechter CB, et al. Post-disaster stressful life events and WTC-related posttraumatic stress, depressive symptoms, and overall functioning among responders to the World Trade Center disaster. J Psychiatr Res. 2015;61:97–105.
   PubMed Web of Science ®Google Scholar
• Savitz DA, Oxman RT, Metzger KB, et al. Epidemiologic research on man-made disasters: strategies and implications of cohort definition for World Trade Center worker and volunteer surveillance program. Mt Sinai J Med. 2008;75:77–87.
   PubMedGoogle Scholar
• Hill AB, The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.
   PubMed Web of Science ®Google Scholar
• Acquavella JF, Friedlander BR, Ireland BK. Interpretation of low to moderate relative risks in environmental epidemiologic studies. Annu Rev Public Health. 1994;15:179–201.
   PubMed Web of Science ®Google Scholar
• Lees-Haley PR, Williams CW. Neurotoxicity of chronic low-dose exposure to organic solvents: a skeptical review. J Clin Psychol. 1997;53:699–712.
   PubMed Web of Science ®Google Scholar
• Woodside FC III, Lydon DR. Litigation bias. N Eng J Med. 1983;308:1604.
   PubMed Web of Science ®Google Scholar
• Kelly K. The Myth of 10−6 As a Definition of Acceptable Risk. 84th Annual Meeting of the Air and Waste Management Association. Vancouver, BC, Canada: Environmental Toxicology International, Inc.; 1991.
   Google Scholar
• Fewtrell L, Bartram J, editors. Water Quality – Guidelines, Standards and Health: Assessment of risk and risk management for water-related infectious disease. London, UK: World Health Organization; 2001.
   Google Scholar
• US Occupational Safety and Health Administration. Occupational Exposure to Asbestos; 1994.
   Google Scholar
• UK Health and Safety Executive. Reducing risks, protecting people – HSE's decision-making process. Norwich, UK: Her Majesty's Stationery Office; 2001.
   Google Scholar
• Bellinger DC. Interpretation of small effect sizes in occupational and environmental neurotoxicology: individual versus population risk. Neurotoxicology. 2007;28:245–251.
   PubMed Web of Science ®Google Scholar
• Hoel D, Kaplan N, Anderson M. Implication of nonlinear kinetics on risk estimation in carcinogenesis. Science. 1983;219:1032–1037.
   PubMed Web of Science ®Google Scholar
• Juni RL. Hormesis and toxic torts: traditional torts and claims for subclinical harm. Hum Exp Toxicol. 2008;27:109–112.
   PubMed Web of Science ®Google Scholar
• Alexander FE. Clusters and clustering of childhood cancer: a review. Eur J Epidemiol. 1999;15:847–852.
   PubMed Web of Science ®Google Scholar
• Wold KS, Byers T, Crane LA, et al. What do cancer survivors believe causes cancer? (United States). Cancer Causes Control. 2005;16:115–123.
   PubMed Web of Science ®Google Scholar
• Collins JJ, Jammer B, Sladeczek FM, et al. Surveillance for angiosarcoma of the liver among vinyl chloride workers. J Occup Environ Med. 2014;56:1207–1209.
   PubMed Web of Science ®Google Scholar
• Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness – the curious resilience of the $50,000-per-QALY threshold. N Eng J Med. 2014;371:796–797.
   PubMed Web of Science ®Google Scholar